A new article from Jarrard Phillips Cate & Hancock, Inc. examines the fate of healthcare transactions in the COVID-19 era. PYA Principal Michael Ramey is among the industry experts interviewed in “Of Pasta and Predictions…M&A Insights From 15 Industry Experts.” He answers questions about the pace of transactions and the greatest barriers to deals today.
Article excerpt:
Deals are being restructured, where legally possible, through earnouts, higher residual equity stakes, and other mechanisms to shift some of the ongoing operational risk to sellers. Furthermore, more scrutiny is being applied in due diligence to evaluate the pace and sustainability of operational rebound, as well as the compliance matters associated with taking government relief funds and loans.
Read the full article.
If you have questions about mergers and acquisitions or would like additional COVID-19 guidance, visit PYA’s COVID-19 hub or contact a PYA executive below at (800) 270-9629.
